Review
Oct 2026
Feasibility and Accuracy of Circulating Tumor DNA (ctDNA) in Assessing Response to Chemotherapy, Prognostication, and Guiding Therapy in Ovarian Cancer: A Review of Literature and Future Directions
Current evidence supports ctDNA's role as a prognostic and molecular monitoring biomarker; however, routine clinical implementation should await robust prospective evidence demonstrating that ctDNA-guided therapeutic strategies improve clinically meaningful patient outcomes.
S. V. Tejas, S. Anusha
· Indian Journal of Gynecologi... · 0 citations